A new era in the treatment of advanced pancreatic cancer may soon be on the way. An experimental oral drug called daraxonrasib has just shown remarkable results in a late stage clinical trial. On Monday,...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/e22030f5-8d3b-4d77-bca6-62f8c538e4db)